A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF THE SUFENTANIL NANOTAB PCA SYSTEM/15 MCG (ZALVISO™) FOR THE TREATMENT OF POST-OPERATIVE PAIN IN PATIENTS AFTER OPEN ABDOMINAL SURGERY: